Wegovy is a premier semaglutide injection available through once-weekly administration, delivering substantial weight management benefits
It prevents large spikes in glucose after meals by slowing the release of sugars into the bloodstream
Lets take a closer look at what semaglutide maintenance dosing may look like so you have a better idea of what to expect
FDA-approved for T2D with proven HbA1c reduction in SURPASS trials Maximizing Energy Expenditure Survodutide Glucagon receptor activation increases resting energy expenditure and thermogenesis, providing a catabolic component absent from GIP/GLP-1 dual agonists Patients with Hepatic Steatosis Survodutide The glucagon component uniquely drives hepatic lipid oxidation, potentially offering greater liver fat reduction than GIP/GLP-1 approaches Continue Your Research Get comparison updates We publish new head-to-head comparisons regularly
New or worsening symptoms such as persistent heartburn, difficulty swallowing, or blood in vomit (bright red or coffee-ground appearance) or black, tarry stools require evaluation to exclude complications like gastrointestinal bleeding
Obesity or overweight conditions with at least one weight-related health issue (e.g., high blood pressure, high cholesterol)
